JAK/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies.
Rah B, Rather RA, Bhat GR, Baba AB, Mushtaq I, Farooq M, Yousuf T, Dar SB, Parveen S, Hassan R, Mohammad F, Qassim I, Bhat A, Ali S, Zargar MH, Afroze D.
Rah B, et al. Among authors: yousuf t.
Front Pharmacol. 2022 Mar 24;13:821344. doi: 10.3389/fphar.2022.821344. eCollection 2022.
Front Pharmacol. 2022.
PMID: 35401182
Free PMC article.
Review.